Positive rejections for latest NICE IPPs
This article was originally published in Clinica
Executive Summary
The two innovative technologies on which the UK's National Institute for Health and Clinical Excellence (NICE) issued guidance this week were deemed not to have the long-term efficacy data required by the agency. But the interventional procedure programme (IPP) appraisals of "implantation miniature lens systems for advanced age-related macular degeneration" and "total wrist replacement" were notably positive in highlighting the evolving nature of these technologies and their prospective review. The next round of IPP guidelines, due out on September 24, will cover: autologous pancreatic islet cell transplantation for improved glycaemic control after pancreatectomy; and balloon catheter dilation of paranasal sinus ostia for chronic sinusitis.